Cannabis Legalization Next States: 2026 Guide
Which states are next to legalize cannabis? See the 2026 ballot candidates, active bills in Pennsylvania, Wisconsin, Hawaii, and Florida, and what decides the votes.
Most potential medical cannabis states are down to a short list. About 39 states allow some form of medical cannabis, leaving Kansas and Idaho with no working program and Wisconsin with a CBD-only law. Nebraska and Wyoming have approved limited programs on paper, but both face slow rollouts, so patients in those states are still waiting for dispensaries to open.
The holdouts fall into two groups: states with no program at all and states with laws that allow CBD but block THC.
These three states appear on nearly every list of potential medical cannabis states for the next legislative cycle.
federal cannabis legalization impact on states
Legislative history, polling, and committee activity point to a few states where a medical bill has a real path to passage.
where is marijuana legal in the us 2025
Kansas has debated medical cannabis bills for years, and a medical-only framework has advanced further than full adult-use proposals. Supporters frame the issue around chronic pain, epilepsy, and veterans. Passage would likely require leadership in the state Senate to allow a floor vote.
Idaho has one of the strictest cannabis laws in the country, and its constitution makes citizen initiatives harder to pass. Medical cannabis would most likely arrive through the legislature rather than a ballot measure. Any bill would probably start narrow, covering severe epilepsy or terminal illness.
Wisconsin has a CBD-only statute, and the governor has publicly backed a medical cannabis plan. Republican leaders have floated limited medical proposals in past sessions. A compromise built around state-run or tightly licensed dispensaries is the most realistic outcome.
Nebraska voters approved medical cannabis by ballot measure, and Wyoming enacted a narrow program for seizure patients. Both face rulemaking, licensing, and legal challenges before products reach shelves. Patients in these states sit in a gray zone where the law exists but access does not.
Several states already allow low-THC products and may widen those laws instead of writing new ones.
Three forces show up in almost every successful campaign.
Federal reform also shifts the calculus. When Washington signals movement on banking or rescheduling, state legislators grow less worried about conflict with federal agencies.
Passing a bill is the first step, not the last. States typically need 12 to 24 months for rulemaking, grower licensing, testing labs, and dispensary openings. Programs with legal challenges or no state agency to run them can take three years or more.
Nebraska and Wyoming are useful examples of that lag. The laws passed, but patient access depends on rules that are still being written.
Track your state legislature's health committee calendar and submit written testimony if a bill is scheduled. Ask your physician whether any legal CBD or low-THC option fits your condition today. Keep records of diagnoses and treatments, since those documents speed up a future application.
Do not buy cannabis from unlicensed sellers. Unregulated products carry risks around pesticides, mold, and dosing that state testing rules are designed to catch.
About 39 states plus the District of Columbia allow some form of medical cannabis. Roughly a dozen of those programs cap THC or limit qualifying conditions to a handful of diagnoses.
Yes, and Nebraska did exactly that in 2024. Ballot campaigns need signature drives and funding, which is why legislatures often move first in states with strict initiative rules.
Federal rescheduling and banking reform would remove some friction, but they would not legalize medical cannabis nationwide. State legislatures still control their own programs, patient registries, and dispensary rules.